Keyphrases
Baseline Risk
16%
Bleeding Risk
16%
Characteristic Risk
16%
Characteristics Method
16%
Clinically Significant
33%
Clostridium Difficile Infection
16%
Cochrane Library
16%
Confidence Interval
100%
Critically Ill Patients
100%
Drug Efficacy
16%
Drug Safety
16%
Embase
16%
Gastrointestinal Bleeding
33%
Histamine-2 Receptor Antagonists (H2RA)
66%
Intensive Care Unit
16%
MEDLINE
16%
Meta-analysis
16%
Network Meta-analysis
100%
Odds Ratio
100%
Placebo
50%
Pneumonia
50%
Prevention Strategies
16%
Proton Pump Inhibitors
66%
Randomized Clinical Trial
16%
Randomized Controlled Trial
16%
Randomized Trial
100%
Risk of Bias
16%
Stress Ulcer Prophylaxis
100%
Sucralfate
83%
Nursing and Health Professions
Clostridium Difficile Infection
16%
Cochrane Library
16%
Confidence Interval
100%
Gastrointestinal Hemorrhage
33%
Intensive Care Unit
16%
Meta Analysis
16%
Network Meta-Analysis
100%
Odds Ratio
100%
Placebo
50%
Proton Pump Inhibitor
66%
Stress Ulcer
100%
Sucralfate
83%
Systematic Review
16%
Medicine and Dentistry
Clostridium Difficile Infection
16%
Gastrointestinal Bleeding
33%
H2 Antagonist
66%
Intensive Care Unit
16%
Meta-Analysis
16%
Network Meta-Analysis
100%
Odds Ratio
100%
Placebo
50%
Proton-Pump Inhibitor
66%
Randomized Clinical Trial
16%
Randomized Controlled Trial
16%
Stress Ulcer
100%
Sucralfate
83%
Systematic Review
16%
Pharmacology, Toxicology and Pharmaceutical Science
Clostridium Difficile Infection
20%
Gastrointestinal Hemorrhage
40%
Histamine H2 Receptor Antagonist
80%
Placebo
60%
Proton Pump Inhibitor
80%
Randomized Clinical Trial
20%
Randomized Controlled Trial
20%
Stress Ulcer
100%
Sucralfate
100%